Literature DB >> 13016601

Prothrombin and accessory factors; clinical significance.

P A OWREN.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; PROTHROMBIN

Mesh:

Substances:

Year:  1953        PMID: 13016601     DOI: 10.1016/0002-9343(53)90019-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  19 in total

1.  INTRACRANIAL HAEMORRHAGE IN HAEMOPHILIA.

Authors:  C B KERR
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-04       Impact factor: 10.154

2.  Hemostasis in a case of tropical sprue with bleeding diathesis.

Authors:  J F WALLACE; T W SHEEHY
Journal:  Am J Dig Dis       Date:  1962-04

3.  [The hirudin test, a micromethod for control of the prothrombin level in anticoagulant therapy].

Authors:  R SCHMUTZLER; F MARKWARDT
Journal:  Klin Wochenschr       Date:  1962-08-01

4.  Enzymes and blood clotting. I. Trypsin as an accessory factor.

Authors:  J H FERGUSON; E G WILSON; S G IATRIDIS; H A RIERSON; B R JOHNSTON
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

5.  Chromatographic purification of human serum accelerator globulin.

Authors:  F M COX; G F LANCHANTIN; A G WARE
Journal:  J Clin Invest       Date:  1956-01       Impact factor: 14.808

6.  Biochemical genetics of blood coagulation.

Authors:  J B GRAHAM
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

7.  [Congenital familial hypoproconverteinemia].

Authors:  U M SERAFINI; F PERICOLI
Journal:  Blut       Date:  1957-05

8.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors:  C HOUGIE; E M BARROW; J B GRAHAM
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

9.  Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials.

Authors:  J H LEWIS; D WALTERS; P DIDISHEIM; W R MERCHANT
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

10.  Asolectin separation of prothrombin from proconvertin.

Authors:  A J SEAMAN; P A OWREN
Journal:  J Clin Invest       Date:  1956-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.